Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for alpha-tubulin binding (biogroup)
Most Correlated Studies
- Tumor formation by ATG5 KO cells
- Kidneys from male C57BL6 mice 28 days after left proximal ureter ligations
- Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
- Glomerulonephrotic and healthy tissue from C57BL6.MRLc1 congenic mice
- Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
Most Relevant Literature
- Factors affecting solubilization of a poorly soluble novel tubulin-binding agent.
- Tubulin binds to the cytoplasmic loop of TRESK background K⁺ channel in vitro.
- A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, an…
- ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.
- Structural basis of protein condensation on microtubules underlying branching microtubule nucleation…
Most Relevant Clinical Trials
- Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer
- Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies
- A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours
- Study of TPI 287 in Patients With Advanced Malignancies
- COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF
